Results 301 to 310 of about 2,557,779 (357)

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

open access: yesMolecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian   +10 more
wiley   +1 more source

[Experience of euthanasia in primary care teams]. [PDF]

open access: yesAten Primaria
Peguero-Rodríguez E   +2 more
europepmc   +1 more source

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

open access: yesMolecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga   +8 more
wiley   +1 more source

Body modification technologies and transvestite and trans people in Argentina: A quantitative study on inequalities in use and access. [PDF]

open access: yesSalud Colect
Farji Neer A   +7 more
europepmc   +1 more source

Understanding the perspectives of older adults and physiotherapists on home-based lower-limb exoskeletons. [PDF]

open access: yesWearable Technol
Claeys R   +10 more
europepmc   +1 more source

[Determinants of trust and acceptance of vaccines in the Dominican RepublicDeterminantes da confiança nas vacinas e sua aceitação na República Dominicana]. [PDF]

open access: yesRev Panam Salud Publica
Colomé-Hidalgo M   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy